The technologies and ideas that underlie e-Science in providing seamless access to distributed resources is a compelling one and has been applied in many research domains. The clinical domain is one area in particular that, in principle has much to be gained from e-Science approaches. Until now however it has largely been the case that the practical realization, support and adoption of e-Science solutions in a clinical setting have been fraught by many hurdles. Not least is trust of technologies and their use in the field as opposed to demonstrator projects with non-real clinical data to prove the merit of e-Science ideas and solutions. The National e-Science Centre (NeSC– www.nesc.ac.uk) at the University of Glasgow have had a large number...
Although individually uncommon, rare diseases (RDs) collectively affect 6-8% of the population; arou...
Rare diseases have been an increasing area of focus as three waves have converged in recent years: t...
As clinical trials and epidemiological studies become increasingly large, covering wider (national) ...
Background: Implementing RD cohorts is a challenge since RDs are seldom, often underdiagnosed and sp...
The final, definitive version of this paper has been published in Health Informatics Journal, Vol 14...
Copyright confirmation in progress. Any queries to UMER-enquiries@unimelb.edu.auAs the proliferatio...
International audienceBackground: Rare diseases (RDs) affect nearly 3 million people in France and a...
Background: The European Reference Networks, ERNs, are virtual networks for healthcare providers acr...
<p><strong>Abstract:</strong></p> <p>Despite many examples of excellent practice, rare disease (RD) ...
Background: The European Reference Network on Rare Multisystemic Vascular Diseases (VASCERN) was lau...
Background: There exists a large number of rare and complex diseases that are neglected due to the d...
The National e-Science Centre at the University of Glasgow has been involved in a portfolio of clini...
Growing awareness of the genetic basis of disease is transforming the opportunities for improving pa...
Abstract Biomedical research is becoming increasingly large-scale and international. Cloud computing...
Objective: We provide an e-Science perspective on the workflow from risk factor discovery and classi...
Although individually uncommon, rare diseases (RDs) collectively affect 6-8% of the population; arou...
Rare diseases have been an increasing area of focus as three waves have converged in recent years: t...
As clinical trials and epidemiological studies become increasingly large, covering wider (national) ...
Background: Implementing RD cohorts is a challenge since RDs are seldom, often underdiagnosed and sp...
The final, definitive version of this paper has been published in Health Informatics Journal, Vol 14...
Copyright confirmation in progress. Any queries to UMER-enquiries@unimelb.edu.auAs the proliferatio...
International audienceBackground: Rare diseases (RDs) affect nearly 3 million people in France and a...
Background: The European Reference Networks, ERNs, are virtual networks for healthcare providers acr...
<p><strong>Abstract:</strong></p> <p>Despite many examples of excellent practice, rare disease (RD) ...
Background: The European Reference Network on Rare Multisystemic Vascular Diseases (VASCERN) was lau...
Background: There exists a large number of rare and complex diseases that are neglected due to the d...
The National e-Science Centre at the University of Glasgow has been involved in a portfolio of clini...
Growing awareness of the genetic basis of disease is transforming the opportunities for improving pa...
Abstract Biomedical research is becoming increasingly large-scale and international. Cloud computing...
Objective: We provide an e-Science perspective on the workflow from risk factor discovery and classi...
Although individually uncommon, rare diseases (RDs) collectively affect 6-8% of the population; arou...
Rare diseases have been an increasing area of focus as three waves have converged in recent years: t...
As clinical trials and epidemiological studies become increasingly large, covering wider (national) ...